Literature DB >> 31415768

Peptide dendrimers as valuable biomaterials in medical sciences.

Fatemeh Sadat Tabatabaei Mirakabad1, Maryam Sadat Khoramgah1, Kamyar Keshavarz F2, Maryam Tabarzad3, Javad Ranjbari4.   

Abstract

Peptides are oligomers of amino acids, which have been used in a wide range of applications, particularly in medical and pharmaceutical sciences. Linear peptides have been extensively developed in various fields of medicine as therapeutics or targeting agents. The branched structure of peptide dendrimers with peptide (commonly, poly l‑Lysine) or non-peptide (commonly poly‑amidoamine) core, often exhibits valuable novel features, improves stability and enhances the functionality of peptide in comparison with small linear peptides. The potential applications of Branched and hyper-branched peptidic structures which are known as peptide dendrimers in biomedical sciences have been approved vastly. A peptide dendrimer contains three distinct parts including core, building blocks and branching units or surface functional groups. These structures provide a lot of opportunities in the pharmaceutical field, particularly for novel drug development. In this review, a brief summary of different biomedical applications of peptide dendrimers is presented, and peptide dendrimers as active pharmaceutical ingredients and drug delivery carriers are discussed. Applications of peptide dendrimers in vaccines and diagnostic tools are also presented, in brief. Generally, peptide dendrimers are promising biomaterials with high evolution rate for clinical and non-clinical applications in medicine.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioactivity; Dendrimer; Diagnostic; Peptide; Therapeutic

Mesh:

Substances:

Year:  2019        PMID: 31415768     DOI: 10.1016/j.lfs.2019.116754

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

Review 1.  Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.

Authors:  Vincent Lenders; Xanthippi Koutsoumpou; Ara Sargsian; Bella B Manshian
Journal:  Nanoscale Adv       Date:  2020-08-24

Review 2.  Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.

Authors:  Xiang Li; Abid Naeem; Shanghua Xiao; Lei Hu; Jing Zhang; Qin Zheng
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

3.  Gold(III) Aryl Complexes as Reagents for Constructing Hybrid Peptide-Based Assemblies via Cysteine S-Arylation.

Authors:  Julia M Stauber; Arnold L Rheingold; Alexander M Spokoyny
Journal:  Inorg Chem       Date:  2021-03-19       Impact factor: 5.165

4.  Investigating Active Learning and Meta-Learning for Iterative Peptide Design.

Authors:  Rainier Barrett; Andrew D White
Journal:  J Chem Inf Model       Date:  2020-12-22       Impact factor: 4.956

5.  Self-assembly of Peptide dendrimers and their bio-applications in theranostics.

Authors:  Fengjuan Xie; Rongxin Li; Weikang Shu; Liang Zhao; Jingjing Wan
Journal:  Mater Today Bio       Date:  2022-03-08

Review 6.  1,2,3-Triazoles as Biomimetics in Peptide Science.

Authors:  Naima Agouram; El Mestafa El Hadrami; Abdeslem Bentama
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

Review 7.  Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases.

Authors:  Nina Filipczak; Satya Siva Kishan Yalamarty; Xiang Li; Farzana Parveen; Vladimir Torchilin
Journal:  Molecules       Date:  2021-05-31       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.